They argue that the economic crisis was not
caused by government action but by government inaction in not reining in the free market.
Not exact matches
Important factors that could
cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment
by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders
by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending
by the U.S. and other
governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory
actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign
government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and
government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven
by federal and state grant cycles which may not mirror patient demand and may
cause fluctuations in Gilead's earnings; market share and price erosion
caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other
government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held
by wholesalers and retailers which may
cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may
cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Many factors could
cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied
by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue
by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied
by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to
government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of
actions of activist shareholders;
government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.
Baby Milk
Action press release 10 June 2014 Baby Milk
Action is today joining colleagues around the world calling on
governments to support international efforts to strengthen international law, thereby better protecting people from human rights abuses
caused by corporate activities.
Following the address, some members of the party have challenged the party's founder saying the party's defeat was not
caused by the
actions of the individuals in
government.
They were joined
by good
government groups, including Citizen
Action, Citizens Union, Common
Cause, LWVNYS, NYPIRG, and Reinvent Albany.
Finding
by PRNigeria revealed that the
action of Magu in instituting criminal charges against Umar has
caused serious confusion and embarrassment to the Federal
Government because the EFCC reports had made clear that the CCT boss had no case to answer.
He said the
government is only making frantic efforts to
cause public disaffection towards the previous NDC administration
by smearing former state officials with allegations of corruption and initiating legal
action against them for same.
He is scathing about the excessive cost of local
government, cutting his own salary
by more than half and seeking to rid the council of waste and bureaucracy, but some of his
actions and remarks have
caused upset — he recently praised the family values of the Taliban, and pledged to cut funding for Gay Pride events in the town before changing his mind.
Dropping the lower threshold of the «likely» range
by half a degree is unlikely to
cause world
governments to scrap their climate
action plans, he said.
«We welcome
action on child poverty but the
Government must remember that poverty is
caused by a complex range of factors.
A delay
caused by a strike or
by picketing which constitutes an unfair labor practice is not excusable unless the Contractor takes all reasonable and appropriate
action to end such a strike or picketing, such as the filing of a charge with the National Labor Relations Board, the use of other available
Government procedures, and the use of private boards or organizations for the settlement of disputes.
The Canadian mortgage trends were already a
cause for concern and this new development required immediate
action by the
government.
The overall economic down turn did
cause some problems but because of timely
action taken
by the
government, the situation was handled with minimal damage.
RBC Bank and Montrose Travel agency will not be liable for delays and cancellations
caused by strikes, labor disputes,
government actions, weather, or any other
causes beyond the control of RBC Bank or Montrose Travel.
RBC Bank and Montrose Travel will not be liable for delays and cancellations
caused by strikes, labor disputes,
government actions, weather, or any other
causes beyond the control of RBC Bank and Montrose Travel.
· RBC Bank will not be liable for delays or cancellations
caused by strikes, labor disputes,
government actions, weather or any other
causes beyond RBC Bank's control.
In short to blame Global Warming, (even it is
caused by man) for starvation and death is to ignore the deliberate state policies that either destroyed their countries economies such as Zimbawe, North Korea, or the criminal
actions such as the Sudanese
government and its campaign of ethnic cleansing in Darfur.
Scientists are 95 per cent certain that humans have
caused recent temperature rises The seas are set to reach higher - than - expected levels
by the end of the century But experts fear the report will fail to spur serious
government action Development experts and scientists have reacted cautiously to leaked versions of the first part of the [continue reading...]
... the Intergovernmental Panel on Climate Change, which includes more than 3,000 scientists from around the world, agrees that climate change is
caused by a number of factors, including excess carbon dioxide... The
Government of Alberta accepts the findings of the Intergovernmental Panel on Climate Change and recognizes the need to reduce emissions and take immediate
action to deal with the impacts of global warming.
The first statute, the Medical Care Recovery Act («MCRA»), 42 U.S.C. § § 2651 - 2653, provides the
Government with a
cause of
action to recover certain specified health care costs it pays to treat individuals injured
by a third - party's tortious conduct (Count 1).
Finally, the UK head of Shell, Lord Oxburgh, took time out - just before his company reported record profits mainly achieved
by selling oil, one of the main
causes of the problem - to warn that unless
governments take urgent
action there «will be a disaster».
Alpha said its
actions «are being triggered
by persistent weakness in U.S. and overseas coal demand and depressed price levels, along with
government regulations that are
causing electric utilities to close coal - fired power plants and forgo new construction.»
In September 2003, Greenpeace obtained evidence in the form of a [http://www.greenpeace.org/international/news/investigation-of-exxon-front-g memo] to Philip A. Cooney dated March 2002, outlining their strategy for dealing with the problems
caused by scientifically - based «Climate
Action Report 2002», which the US
government had submitted to the UN.
penalizes the defendant for engaging in public participation «plaintiff» means a person who initiates or maintains a proceeding against a defendant; «proceeding» means any
action, suit, matter,
cause, counterclaim, appeal, or originating application that is brought in the Supreme Court or the Provincial Court, but does not include a prosecution for an offence or a crime; «public interest» means the whole of the subject matter invites public attention, or a matter in which the public has some substantial concern because it affects the welfare of citizens, or one to which considerable public notoriety or controversy has attached; «public participation» means communication or conduct aimed at influencing public opinion, or promoting further lawful
action by the public or any
government body, in relation to an issue of public interest; «Strategic Lawsuit Against Public Participation (SLAPP)» means a claim that arises from a form of expression or public participation,
by the person against whom the claim is asserted that was made in connection with an official proceeding or about a matter of public interest; Purposes of this Act: 2 The purposes of this Act are to a) Establish a statutory right to public participation for every individual; b) Encourage individuals to express themselves on matters of public interest; c) Promote broad participation in debates on matters of public interest; d) Discourage the use of litigation as a means of unduly limiting expression on matters of public interest; and, e) Preserve the right of access to the courts for all proceedings and claims that are not brought or maintained for an improper purpose.
If you have been injured and left to cope with the painful aftermath of an accident
caused by the negligent
actions of a
government agency in Washington State, you have the right to pursue damages.
Such
action would take the form of «climate accountability letters» sent
by the local
governments, demanding fossil companies to take responsibility for the harm their product are
causing, but we are also asking the local
governments to consider bringing a class
action lawsuit — a joint lawsuit on behalf of all BC local
governments — against some of the world's largest fossil fuel cartels.
However, as a general rule,
government entities are not liable for injuries
caused by their negligent
actions related to carrying out
government business.
Our second
action encompassed a two - tier suit calling for the annulment of the illegal act incurred
by a
government institution, and the restitution of
caused damages.
They address the underlying
causes of human rights abuse, they help to bring change at the highest levels of society,
by compelling
government and international institutions to take
action.
The North American Indian Brotherhood (NAIB) was established in the late 1940's, but like its predecessor, the NAIB's efforts were hindered
by a lack of nation - wide support and suppressive
government actions,
causing it to be disbanded
by the early 1950's.
The law says that if
government «inordinately burdens» private real property, the landowner may seek payment in court for the decrease in value
caused by the
action.